Skip to main content
TipRanks
Go Ultimate75% OFF

Inovio Pharmaceuticals (GBM) Q3 2022 Earnings Report

1 Followers

CH:GBM Q3 2022 EPS Results

Actual EPS
-CHF 1.52
Consensus EPS
-CHF 2.95
Beat/Miss
Beat by +CHF 1.43
One Year Ago EPS
-CHF 2.93

CH:GBM Q3 2022 Revenue Results

Actual Revenue
CHF 7.72M
Expected Revenue
CHF 525.31K
Beat/Miss
Beat by +CHF 7.19M
YoY Revenue Growth
+3038.22%

Earnings Announcement Details

Quarter
Q3 2022
Date
11/08/2022
Time
After Close
Conference Call
Tuesday, November 8, 2022
CH:GBM Upcoming Earnings

Inovio Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

CH:GBM Q3 2022 Earnings Call
0:00 / 0:00

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:GBM Earnings History

CH:GBM earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)-0.11-0.05――
Nov 10, 20262026 (Q3)-0.17-0.42-0.7342.53% (+0.31)
Aug 12, 20262026 (Q2)-0.18-0.06-0.5188.52% (+0.46)
May 13, 20262026 (Q1)-0.30-0.24-0.4345.10% (+0.19)
Mar 12, 20262025 (Q4)-0.300.05-0.55109.23% (+0.60)
Nov 10, 20252025 (Q3)-0.36-0.73-0.752.25% (+0.02)
Aug 12, 20252025 (Q2)-0.51-0.51-148.74% (+0.49)
May 13, 20252025 (Q1)-0.58-0.43-1.161.07% (+0.67)
Mar 18, 20252024 (Q4)-0.71-0.55-0.9340.91% (+0.38)
Nov 14, 20242024 (Q3)-0.97-0.75-1.3242.95% (+0.56)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed